Definitive Contract W81XWH20C0076
Award Date
6/5/20
Potential Completion Date
6/4/21
Potential Value
$1.1M
Federal Agency
Medical Command
Awardee
Biofire Defense LLC
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Salt Lake City, UT 84107, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of the Army Medical Command awarded a $2.667 million cost-plus-fixed-fee contract to Biofire Defense LLC. The contract supports sample type expansion studies for Biofire Defense's COVID-19 test under Emergency Use Authorization. Per the original solicitation, the objective is to expand the utility of Biofire Defense's COVID-19 test system through studies of anterior nares swab and saliva sample types. Performance will take place in Salt Lake City, Utah through February 2023. As...
This is a firm fixed-price delivery order awarded by the Department of the Army Materiel Command Army Contracting Command Aberdeen Proving Ground to Biofire Defense LLC, a limited liability company that manufactures goods. The contract, which has no set-aside designation, is valued at $419,638.50 and is for all project management activities associated with the OY2 PD phase and the Earned Value Management System (EVMS). The work will be performed in Salt Lake City, Utah and was awarded on...
This is a cost-plus-fixed-fee delivery order contract awarded by the Department of the Army Materiel Command Army Contracting Command Aberdeen Proving Ground to Biofire Defense LLC, a for-profit limited liability company manufacturer, for the development of non-Biological Warfare Agent (BWA) environmental assays. The contract has a potential value of $1,759,100.98 and a completion date of September 30, 2019. No set-aside designation is mentioned. Biofire Defense is a provider of biological agent...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $3 million firm fixed price delivery order contract to Biofire Defense LLC of Salt Lake City, Utah. Under the terms of the contract, Biofire Defense will provide commercial assay kits for the RP2.1 assays and COVID-19 assay external control materials to support the Department's coronavirus COVID-19 response efforts. The contract runs from April 24, 2020 through October 31, 2020 and...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $5.9 million firm fixed price delivery order to Biofire Defense LLC. The order is for the purchase of COVID-19 assays, external control materials, and software module updates to support the agency's response to the Coronavirus pandemic. Performance will take place in Salt Lake City, Utah, through December 2020. No set aside designation or subcontractors were indicated. The funding agency...
The Department of Health and Human Services National Institutes of Health Clinical Center awarded a firm-fixed-price purchase order to Biofire Defense LLC, a for-profit limited liability company that manufactures biological identification products. The $12,186.00 contract is for the delivery of 30 Respiratory Panel 2.1 in vitro diagnostic tests. The work will be performed in Salt Lake City, Utah and is expected to be completed by May 2, 2024. Biofire Defense has previously received other federal...
The Department of the Air Force awarded a definitive contract valued at $33.1 million to Biofire Defense LLC of Salt Lake City, Utah. The firm fixed price contract is to provide "COVID 19" BIOFIRE RESPIRATORY 2.1 (RP2.1) PANEL WITH SARS_COV-2 diagnostic testing kits compatible for use on BioFire 2.0, BioFire Torch, and other BioFire analyzers. The solicitation sought proposals to supply these BioFire Respiratory 2.1 panels to detect SARS-CoV-2 and 21 additional respiratory pathogens...
The U.S. Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $417,450 firm-fixed-price delivery order to Biofire Defense LLC, a for-profit limited liability company and manufacturer, for the purchase of COVID-19 assays. This award is not associated with a set-aside program. Biofire Defense has previously provided a range of biological agent identification products, diagnostic assays, and testing platforms to various federal agencies, including...
This contract was awarded by the U.S. Department of the Air Force Air Education and Training Command to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company that specializes in syndromic infectious disease testing. The contract, valued at $160,500.00, is for the provision of COVID-19 testing products and services under a Delivery Order against Biofire's GSA Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. The contract has a completion date of...
This is a firm fixed-price purchase order contract awarded by the U.S. Army Medical Command (MEDCOM) to Biofire Defense LLC, a for-profit limited liability company that manufactures biological threat detection and infectious disease diagnostic products. The contract, valued at $354,449.56, is for the delivery of the Biofire FilmArray instrument, a fully integrated biological agent identification platform. The contract has no set-aside designation and was awarded on July 21, 2015, with a...